ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664W955. A total of 5 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $823,000 | -35.2% | 205 | -25.7% | 0.08% | -56.8% |
Q4 2018 | $1,270,000 | -59.1% | 276 | -60.6% | 0.18% | -39.7% |
Q3 2018 | $3,107,000 | +87.4% | 700 | +65.5% | 0.31% | +113.2% |
Q2 2018 | $1,658,000 | +21.3% | 423 | +123.8% | 0.14% | -11.1% |
Q1 2018 | $1,367,000 | – | 189 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 399 | $3,262,000 | 0.12% |
GROUP ONE TRADING, L.P. | 24,000 | $1,962,000 | 0.03% |
SIMPLEX TRADING, LLC | 221 | $234,000 | 0.02% |
Citadel Advisors | 27,000 | $2,208,000 | 0.00% |